Wenge Xing

Hepatitis C viral load, genotype, and increased risk of developing end‐stage renal disease: REVEAL‐HCV study

Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies

The Spring α-Helix Coordinates Multiple Modes of HCV (Hepatitis C Virus) NS3 Helicase Action

Global epidemiology and genotype distribution of the hepatitis C virus infection

Disparities by province, age, and sex in site-specific cancer burden attributable to 23 potentially modifiable risk factors in China: a comparative risk assessment

Non-alcoholic fatty liver disease – A global public health perspective

Immune Contexture, Immunoscore, and Malignant Cell Molecular Subgroups for Prognostic and Theranostic Classifications of Cancers

The changing epidemiology of liver diseases in the Asia–Pacific region

The immune contexture in cancer prognosis and treatment

Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020

Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression

EASL Recommendations on Treatment of Hepatitis C 2018

Antiretroviral Use in the CEASE Cohort Study and Implications for Direct-Acting Antiviral Therapy in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection

HIV, HCV, and HBV co-infections in a rural area of Shanxi province with a history of commercial blood donation.

Prevalence and risk factors of hepatitis C and B virus infections in hemodialysis patients and their spouses: A multicenter study in Beijing, China

Effect of transcatheter renal arterial embolization combined with cryoablation on regulatory CD4+CD25+ T lymphocytes in the peripheral blood of patients with advanced renal carcinoma

[A sero-epidemiological study on hepatitis C in China].